Committed to supporting independent clinical research
Stryker’s Investigator Initiated Study (IIS) Grants are a part of our commitment to making healthcare better for our customers and their patients.
Your independent research studies are a crucial component in making healthcare better
Stryker helps advance clinical research by supporting independent investigator led research studies
Why partner with Stryker?
Stryker provides support in the form of monetary funding or supply of product(s) to ethical independent clinical research conducted by suitably qualified investigators.
An investigator-initiated study is a research protocol designed and implemented by the principal investigator (PI). The PI acts as the study sponsor responsible for understanding and complying with all regulatory requirements related to the study.
This partnership with independent research investigators is key to our continued commitment in improve healthcare and address unmet clinical needs.
Direct monetary fund
Supply of product(s)
Investigator Initiated Study (IIS) Program guidelines
Who can apply?
We’re looking for professionals or faculty members at an accredited medical or educational institution (applicants with previous research experience and publication history preferred).
Study criteria
- Based on Stryker’s products with clinically relevant outcomes
- Can be an observational, interventional or basic science study
- Access to appropriate facilities and resources to conduct the proposed research
- Rigorous research protocol/journal quality standards
- Must be on-label
The IIS Program generally does not provide support for studies that involve investigational/pre-cleared/pre-market devices or off-label use of product.
Solve a clinical problem/need
Clinical observations requiring investigation
Sonopet/Pulse Control & Blood Loss
Cognitive Load and AI/CGI
Retrospective Allograft Bone Fusion Study with economic value
2023-2024 funding calls
Jan 2024 funding
Round 1
Application open ……………………………….……. April 03 – May 26
Review ………………………………………………… May 30 – June 30
Announcement ……………………………………….. June 18-28
Round 2*
Application open ……………………………….……. August 08 – September 28
Review ………………………………………………… October 03 – November 07
Announcement ……………………………………….. December 05-15
*Depending on Round 1 results. Round 2 is subject to change.
Program process
Expression of interest
- Proposal overview
- Estimate budget
- Investigator CV
Clinical council review
- Review within 30 days
- Initial approval to proceed
- Rejection with request to review and resubmit
- Rejection
Submission of full protocol
- Full review
- Contract negotiation
- Research agreement
- Funding schedule
- Milestone agreement
Full study approval
- Study initiated
- Support provided as per agreement
- Agreed milestones achieved
- Full peer review publication
Get started
Request additional information
Complete the form to ask questions or let to let us know that you are interested. We’d love to help you get started.
Lisa O’Sullivan
Clinical Research Portfolio Manager
Bradley Allen
Clinical Research Manager
Ilka Meinert
Associate Clinical Research Manager
